Drugs / autologous lymphoma-derived idiotype vaccine
autologous lymphoma-derived idiotype vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00006478 | Oct 2000 → Apr 2008 | lymphoma | University of Nebraska | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous lymphoma-derived idiotype vaccine | “Patients receive autologous lymphoma-derived idiotype vaccine plus keyhole limpet hemocyanin subcutaneously (SC) on day 1.” NCT00006478 ↗ |
| Modality | Vaccine | “autologous lymphoma-derived idiotype vaccine” NCT00006478 ↗ |
| Route | Subcutaneous | “autologous lymphoma-derived idiotype vaccine plus keyhole limpet hemocyanin subcutaneously (SC)” NCT00006478 ↗ |